Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials.

Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respir Res (2015) 1.11

The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies. Respir Res (2016) 0.85

A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis (2015) 0.81

Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease. NPJ Prim Care Respir Med (2016) 0.79

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis. Int J Chron Obstruct Pulmon Dis (2016) 0.77

Does COPD risk vary by ethnicity? A retrospective cross-sectional study. Int J Chron Obstruct Pulmon Dis (2016) 0.76

Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD). Health Qual Life Outcomes (2016) 0.75

Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm. Int J Chron Obstruct Pulmon Dis (2017) 0.75

Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management. Adv Ther (2016) 0.75

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Respir Res (2016) 0.75

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92

The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J (1959) 12.70

Development and first validation of the COPD Assessment Test. Eur Respir J (2009) 8.06

St. George's Respiratory Questionnaire: MCID. COPD (2005) 3.99

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health (2011) 3.63

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding. Value Health (2011) 3.45

The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27

Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax (1991) 2.93

Definition, epidemiology and natural history of COPD. Eur Respir J (2007) 2.47

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax (1999) 2.15

Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med (2010) 2.09

Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J (2011) 2.08

Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med (2014) 2.00

Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study. COPD (2013) 1.45

The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest (2003) 1.38

The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med (2006) 1.34

Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale. Respir Med (2003) 1.25

Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health (2010) 1.21

Minimum clinically important improvement for the incremental shuttle walking test. Thorax (2008) 1.19

Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest (2010) 1.07

Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med (2006) 1.05

Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS. COPD (2013) 1.01

Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax (2014) 0.98

Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 0.91

A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium. COPD (2012) 0.86

Assessing patient report of function: content validity of the Functional Performance Inventory-Short Form (FPI-SF) in patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis (2012) 0.84

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD. Respir Med (2011) 0.83

Bronchodilator therapy for chronic obstructive pulmonary disease. Respirology (1997) 0.78

The promise of electronic data capture in respiratory medicine. Eur Respir J (2011) 0.78